PL EN


Preferences help
enabled [disable] Abstract
Number of results
2012 | 17 | 87 - 94
Article title

EVALUATION OF PHYSICOCHEMICAL PROPERTIES OF SOLID DISPERSIONS OF BCS CLASS II SUBSTANCES WITH CHITOSAN

Content
Title variants
Languages of publication
EN
Abstracts
EN
The BCS class II includes drugs with low solubility and high permeability. The substances require modification to increase their solubility in the upper part of the digestive system. Fenofibrate is an example of this class drugs. The aim of the study was to investigate the effect of chitosan on the solubility of fenofibrate incorporated into this polymer carrier. The study investigated fenofibrate in solid dispersions using a method of the solvent evaporation by means of freeze-drying at the drug to polymer ratio of 3:7,5:5,7:3. The study revealed a multi-fold increase (from 33 to 57 times) in fenofibrat solubility in the presence of chitosan, which increased with duration of the study and with increasing percentage of the polymer in formulations. DSC examination revealed a possible physical interaction between the drug and the polymer. The degree of lowering of temperature and increased heat effects is correlated with increased solubility of the drug in all the formulations. DSC studies confirmed that fenofibrate is present in solid dispersions in a crystalline form.
Publisher

Year
Volume
17
Pages
87 - 94
Physical description
Contributors
  • Department Inorganic Chemistry, Medical University of Wrocław
author
  • Faculty of Pharmacy The “Silesian Piast” memorial Medical University of Wroclaw
author
  • Faculty of Pharmacy The “Silesian Piast” memorial Medical University of Wroclaw
References
  • Amidon G.L., Lennernäs H., Shah V.P., Crison J.R..;(1995) A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm. Res. 12, pp. 413-420.
  • Yasir M., Asif M., Kumar A., Aggarval A.;(2010) Biopharmaceutical Classification System: An Account; Int. J. of Pharm. Tech. Res. 2, pp. 1681-1690.
  • Woskowicz M.;(2008) Biofarmaceutyczny system klasyfikacji (BCS) jako nowoczesna metoda oceny właściwości fizykochemicznych i farmakokinetycznych środków leczniczych. Farmacja Polska 64, pp. 191-195.
  • Vogt M., Kunath K., Dressman J.B.;(2008) Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations; Eur. J. of Pharm. and Biopharm. 68, pp.283–288.
  • Guyot M., Fawaz F., Bildet J., Bonini F., Lagueny A.M.;(1995) Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int. J. Pharm.123,pp.53-63.
  • Patel A.R., Vavia P.R.;(2006) Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation; J. of Inc. Phen.And Macr.Chem. 56, pp. 247-251.
  • Saharan V.A., Kukkar V., Kataria M., Gera M., Choudhury P.K.;(2009) Dissolution Enhancement of Drugs. Part I: Technologies and Effect of Carriers.; Int. J. Health Res.2, pp.107-124.
  • Farmakopea Polska VIII, Warszawa: URPL i WB 2008, tom I, str. 1434-1435.
  • Vippagunta S.R.;(2006) Factors affecting the formation of eutectic solid dispersions and their dissolution behavior;)J. Pharm. Sci, 96,pp. 294-304.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-1e79fd2b-af7a-4e71-b888-db6f9a04efe2
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.